Makiko Mizukami

964 citations
28 papers · 756 indexed · h-index 17

Makiko Mizukami

28 papers receiving 745 citations

Peers

Makiko Mizukami
Comparison fields: 5 of 62
  • Immunology 387
  • Oncology 407
  • Pulmonary and Respiratory Medicine 245
  • Cancer Research 90
  • Radiology, Nuclear Medicine and Imaging 77
Replace Tetsuya So with:
Tetsuya So Japan
M Loda United States
Konstantinos Tsaparikos United States
Frank Tsai United States
C. A. Bulanhagui United States
Karine Flem‐Karlsen Norway
David Molkentine United States
C. Guha United States
Heloise M. Halse Australia
Makiko Mizukami relative to Tetsuya So Japan Tetsuya So's profile →
Citations per field
00.5×1.5×
Tetsuya So · 1×
Citations per year

Countries citing papers authored by Makiko Mizukami

Since Specialization
Citations

This map shows the geographic impact of Makiko Mizukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Mizukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Mizukami more than expected).

Fields of papers citing papers by Makiko Mizukami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makiko Mizukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Mizukami. The network helps show where Makiko Mizukami may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Makiko Mizukami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Makiko Mizukami Line = papers co-authored together Makiko Mizukami links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20127
2 20106
3 200912
4 200915
5 200973
6 200810
7 200878
8 200820
9 200830
10 200730
11 200710
12 200772
13 200616
14 200517
15
Molecular genetic tumor markers in non-small cell lung cancer.
200519
16 200414
17 200419
18 200449
19 200214
20 200117

About Makiko Mizukami

Makiko Mizukami is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 756 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Glycosylation and Glycoproteins Research (7 papers), Immune Cell Function and Interaction (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (387 citations), Oncology (407 citations) and Pulmonary and Respiratory Medicine (245 citations). Makiko Mizukami has collaborated with scholars based in Japan. Frequent co-authors include Kosei Yasumoto, Mitsuhiro Takenoyama, Takeshi Hanagiri, Yoshinobu Ichiki, Kenji Sugio, Masakazu Sugaya, Tetsuya So, Manabu Yasuda, Tomoko So and Tetsuro Baba. Their work appears in journals such as Lung Cancer, Cancer Science, Cancer Research, Surgery Today and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026